Introduction
Homozygous familial hypercholesterolemia (HoFH) is a hereditary disease caused by mutations in both parents. HoFH causes LDL cholesterol levels to be very high. Symptoms include macular tumors, chest pain, non-healing of the toes and pain in the toes, chest pain and sores. Treatment includes changing the diet and using Statin drugs.
This report provides a survey of the development of therapeutic drugs for homozygous familial hypercholesterolemia (HoFH), providing a summary of products under development, product overviews at various stages of clinical trials, major corporate profiles, drug profiles, and the latest trends in developing products. Systematic information related to news and press releases.
简体中文